Predictors of Recurrence of Fulminant Bacterial Peritonitis after Discontinuation of Antibiotics in Open Management of the Abdomen

Objective: To assess a scoring system for predicting recurrence of fulminant bacterial peritonitis after discontinuation of antimicrobial treatment in patients being treated by open management of the abdomen for persistent bacterial peritonitis after perforation of the digestive tract, anastomotic d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The European journal of surgery 1998, Vol.164 (11), p.825-829
Hauptverfasser: Visser, Maarten R., Bosscha, Koop, Olsman, Jan, Vos, Aart, Hulstaert, Puck F., van Vroonhoven, Theo J. M. V., van der Werken, Chris
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 829
container_issue 11
container_start_page 825
container_title The European journal of surgery
container_volume 164
creator Visser, Maarten R.
Bosscha, Koop
Olsman, Jan
Vos, Aart
Hulstaert, Puck F.
van Vroonhoven, Theo J. M. V.
van der Werken, Chris
description Objective: To assess a scoring system for predicting recurrence of fulminant bacterial peritonitis after discontinuation of antimicrobial treatment in patients being treated by open management of the abdomen for persistent bacterial peritonitis after perforation of the digestive tract, anastomotic disruption, or necrotising pancreatitis. Design: Retrospective study. Setting: University Hospital, The Netherlands. Subjects: 58 consecutive patients. Main outcome measurements: Recurrence of fulminant bacterial peritonitis and survival. Results: 13 of the 58 patients (22%) died during the initial course of antimicrobial drugs. 14 of the remaining 45 patients had a recurrence of fulminant bacterial peritonitis after discontinuation of antimicrobial drugs, 4 of whom died. Predictive criteria included raised white cell count (WCC) (p ≥ 0.02), duration of initial antibiotic treatment (p ≥ 0.05), and deterioration in Simplified Acute Physiology Score (p ≥ 0.05). Using the WCC and the duration of initial antimicrobial treatment together with other variables that showed a predictive trend (body temperature, percentage band cells, underlying disease, and use of inotropic agents), in a new scoring system (0–12), fulminant bacterial peritonitis did not recur when the score was 0-3, but in 9 of 11 patients with a score of 6 or more it did (p < 0.001). Conclusion: Patients at increased risk of recurrence of fulminant bacterial peritonitis during open management of the abdomen can be identified at the time of discontinuation of antimicrobial treatment by a new scoring system; antimicrobial treatment should not be discontinued in patients with a score of 6 or more.
doi_str_mv 10.3109/110241598750005228
format Article
fullrecord <record><control><sourceid>informahealthcare</sourceid><recordid>TN_cdi_informahealthcare_journals_10_3109_110241598750005228</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_3109_110241598750005228</sourcerecordid><originalsourceid>FETCH-informahealthcare_journals_10_3109_1102415987500052283</originalsourceid><addsrcrecordid>eNqlj81KxEAQhAdRcP15AU_zAtHpZEM24GX9WbyIi3gPvbMd00vSIzOTF_DJ7QVvHj1VV_FVQxlzA-62AtfeAbhyCXW7amrnXF2WqxOzgGYJRVs2cKq3AoUScG4uUjooBFVTLsz3NtKefQ4x2dDbd_JzjCSejm4zjxMLSrYP6DNFxtFuVXIQzpws9hraJ04-SGaZMXOQY3Gtdschs0-Wxb59kdhXFPykifSbEnkgu97tg_orc9bjmOj6Vy_N_eb54_GlYOlDnHAgHPPgMVJ3CHMUZTpw3XF393d39c_6D8rZZl0</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Predictors of Recurrence of Fulminant Bacterial Peritonitis after Discontinuation of Antibiotics in Open Management of the Abdomen</title><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Visser, Maarten R. ; Bosscha, Koop ; Olsman, Jan ; Vos, Aart ; Hulstaert, Puck F. ; van Vroonhoven, Theo J. M. V. ; van der Werken, Chris</creator><creatorcontrib>Visser, Maarten R. ; Bosscha, Koop ; Olsman, Jan ; Vos, Aart ; Hulstaert, Puck F. ; van Vroonhoven, Theo J. M. V. ; van der Werken, Chris</creatorcontrib><description>Objective: To assess a scoring system for predicting recurrence of fulminant bacterial peritonitis after discontinuation of antimicrobial treatment in patients being treated by open management of the abdomen for persistent bacterial peritonitis after perforation of the digestive tract, anastomotic disruption, or necrotising pancreatitis. Design: Retrospective study. Setting: University Hospital, The Netherlands. Subjects: 58 consecutive patients. Main outcome measurements: Recurrence of fulminant bacterial peritonitis and survival. Results: 13 of the 58 patients (22%) died during the initial course of antimicrobial drugs. 14 of the remaining 45 patients had a recurrence of fulminant bacterial peritonitis after discontinuation of antimicrobial drugs, 4 of whom died. Predictive criteria included raised white cell count (WCC) (p ≥ 0.02), duration of initial antibiotic treatment (p ≥ 0.05), and deterioration in Simplified Acute Physiology Score (p ≥ 0.05). Using the WCC and the duration of initial antimicrobial treatment together with other variables that showed a predictive trend (body temperature, percentage band cells, underlying disease, and use of inotropic agents), in a new scoring system (0–12), fulminant bacterial peritonitis did not recur when the score was 0-3, but in 9 of 11 patients with a score of 6 or more it did (p &lt; 0.001). Conclusion: Patients at increased risk of recurrence of fulminant bacterial peritonitis during open management of the abdomen can be identified at the time of discontinuation of antimicrobial treatment by a new scoring system; antimicrobial treatment should not be discontinued in patients with a score of 6 or more.</description><identifier>ISSN: 1102-4151</identifier><identifier>EISSN: 1741-9271</identifier><identifier>DOI: 10.3109/110241598750005228</identifier><language>eng</language><publisher>Informa UK Ltd</publisher><ispartof>The European journal of surgery, 1998, Vol.164 (11), p.825-829</ispartof><rights>1998 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1998</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids></links><search><creatorcontrib>Visser, Maarten R.</creatorcontrib><creatorcontrib>Bosscha, Koop</creatorcontrib><creatorcontrib>Olsman, Jan</creatorcontrib><creatorcontrib>Vos, Aart</creatorcontrib><creatorcontrib>Hulstaert, Puck F.</creatorcontrib><creatorcontrib>van Vroonhoven, Theo J. M. V.</creatorcontrib><creatorcontrib>van der Werken, Chris</creatorcontrib><title>Predictors of Recurrence of Fulminant Bacterial Peritonitis after Discontinuation of Antibiotics in Open Management of the Abdomen</title><title>The European journal of surgery</title><description>Objective: To assess a scoring system for predicting recurrence of fulminant bacterial peritonitis after discontinuation of antimicrobial treatment in patients being treated by open management of the abdomen for persistent bacterial peritonitis after perforation of the digestive tract, anastomotic disruption, or necrotising pancreatitis. Design: Retrospective study. Setting: University Hospital, The Netherlands. Subjects: 58 consecutive patients. Main outcome measurements: Recurrence of fulminant bacterial peritonitis and survival. Results: 13 of the 58 patients (22%) died during the initial course of antimicrobial drugs. 14 of the remaining 45 patients had a recurrence of fulminant bacterial peritonitis after discontinuation of antimicrobial drugs, 4 of whom died. Predictive criteria included raised white cell count (WCC) (p ≥ 0.02), duration of initial antibiotic treatment (p ≥ 0.05), and deterioration in Simplified Acute Physiology Score (p ≥ 0.05). Using the WCC and the duration of initial antimicrobial treatment together with other variables that showed a predictive trend (body temperature, percentage band cells, underlying disease, and use of inotropic agents), in a new scoring system (0–12), fulminant bacterial peritonitis did not recur when the score was 0-3, but in 9 of 11 patients with a score of 6 or more it did (p &lt; 0.001). Conclusion: Patients at increased risk of recurrence of fulminant bacterial peritonitis during open management of the abdomen can be identified at the time of discontinuation of antimicrobial treatment by a new scoring system; antimicrobial treatment should not be discontinued in patients with a score of 6 or more.</description><issn>1102-4151</issn><issn>1741-9271</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqlj81KxEAQhAdRcP15AU_zAtHpZEM24GX9WbyIi3gPvbMd00vSIzOTF_DJ7QVvHj1VV_FVQxlzA-62AtfeAbhyCXW7amrnXF2WqxOzgGYJRVs2cKq3AoUScG4uUjooBFVTLsz3NtKefQ4x2dDbd_JzjCSejm4zjxMLSrYP6DNFxtFuVXIQzpws9hraJ04-SGaZMXOQY3Gtdschs0-Wxb59kdhXFPykifSbEnkgu97tg_orc9bjmOj6Vy_N_eb54_GlYOlDnHAgHPPgMVJ3CHMUZTpw3XF393d39c_6D8rZZl0</recordid><startdate>1998</startdate><enddate>1998</enddate><creator>Visser, Maarten R.</creator><creator>Bosscha, Koop</creator><creator>Olsman, Jan</creator><creator>Vos, Aart</creator><creator>Hulstaert, Puck F.</creator><creator>van Vroonhoven, Theo J. M. V.</creator><creator>van der Werken, Chris</creator><general>Informa UK Ltd</general><scope/></search><sort><creationdate>1998</creationdate><title>Predictors of Recurrence of Fulminant Bacterial Peritonitis after Discontinuation of Antibiotics in Open Management of the Abdomen</title><author>Visser, Maarten R. ; Bosscha, Koop ; Olsman, Jan ; Vos, Aart ; Hulstaert, Puck F. ; van Vroonhoven, Theo J. M. V. ; van der Werken, Chris</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-informahealthcare_journals_10_3109_1102415987500052283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Visser, Maarten R.</creatorcontrib><creatorcontrib>Bosscha, Koop</creatorcontrib><creatorcontrib>Olsman, Jan</creatorcontrib><creatorcontrib>Vos, Aart</creatorcontrib><creatorcontrib>Hulstaert, Puck F.</creatorcontrib><creatorcontrib>van Vroonhoven, Theo J. M. V.</creatorcontrib><creatorcontrib>van der Werken, Chris</creatorcontrib><jtitle>The European journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Visser, Maarten R.</au><au>Bosscha, Koop</au><au>Olsman, Jan</au><au>Vos, Aart</au><au>Hulstaert, Puck F.</au><au>van Vroonhoven, Theo J. M. V.</au><au>van der Werken, Chris</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictors of Recurrence of Fulminant Bacterial Peritonitis after Discontinuation of Antibiotics in Open Management of the Abdomen</atitle><jtitle>The European journal of surgery</jtitle><date>1998</date><risdate>1998</risdate><volume>164</volume><issue>11</issue><spage>825</spage><epage>829</epage><pages>825-829</pages><issn>1102-4151</issn><eissn>1741-9271</eissn><abstract>Objective: To assess a scoring system for predicting recurrence of fulminant bacterial peritonitis after discontinuation of antimicrobial treatment in patients being treated by open management of the abdomen for persistent bacterial peritonitis after perforation of the digestive tract, anastomotic disruption, or necrotising pancreatitis. Design: Retrospective study. Setting: University Hospital, The Netherlands. Subjects: 58 consecutive patients. Main outcome measurements: Recurrence of fulminant bacterial peritonitis and survival. Results: 13 of the 58 patients (22%) died during the initial course of antimicrobial drugs. 14 of the remaining 45 patients had a recurrence of fulminant bacterial peritonitis after discontinuation of antimicrobial drugs, 4 of whom died. Predictive criteria included raised white cell count (WCC) (p ≥ 0.02), duration of initial antibiotic treatment (p ≥ 0.05), and deterioration in Simplified Acute Physiology Score (p ≥ 0.05). Using the WCC and the duration of initial antimicrobial treatment together with other variables that showed a predictive trend (body temperature, percentage band cells, underlying disease, and use of inotropic agents), in a new scoring system (0–12), fulminant bacterial peritonitis did not recur when the score was 0-3, but in 9 of 11 patients with a score of 6 or more it did (p &lt; 0.001). Conclusion: Patients at increased risk of recurrence of fulminant bacterial peritonitis during open management of the abdomen can be identified at the time of discontinuation of antimicrobial treatment by a new scoring system; antimicrobial treatment should not be discontinued in patients with a score of 6 or more.</abstract><pub>Informa UK Ltd</pub><doi>10.3109/110241598750005228</doi></addata></record>
fulltext fulltext
identifier ISSN: 1102-4151
ispartof The European journal of surgery, 1998, Vol.164 (11), p.825-829
issn 1102-4151
1741-9271
language eng
recordid cdi_informahealthcare_journals_10_3109_110241598750005228
source Oxford University Press Journals All Titles (1996-Current)
title Predictors of Recurrence of Fulminant Bacterial Peritonitis after Discontinuation of Antibiotics in Open Management of the Abdomen
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T00%3A23%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-informahealthcare&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictors%20of%20Recurrence%20of%20Fulminant%20Bacterial%20Peritonitis%20after%20Discontinuation%20of%20Antibiotics%20in%20Open%20Management%20of%20the%20Abdomen&rft.jtitle=The%20European%20journal%20of%20surgery&rft.au=Visser,%20Maarten%20R.&rft.date=1998&rft.volume=164&rft.issue=11&rft.spage=825&rft.epage=829&rft.pages=825-829&rft.issn=1102-4151&rft.eissn=1741-9271&rft_id=info:doi/10.3109/110241598750005228&rft_dat=%3Cinformahealthcare%3E10_3109_110241598750005228%3C/informahealthcare%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true